Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Pemetrexed, and RT followed by Docetaxel in Stage III NSCLC
NCT00301808Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Nov 2005
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Barbara Ann Karmanos Cancer Institute. Started Nov 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00301808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301808.